Insulet Corp. appoints new chief commerical officer

BEDFORD, Mass. A company that develops insulin-pump technology without tubing, such as the OmniPod Insulin Management System, has created a new executive position.

Insulet Corp. announced this week the appointment of Peter Devlin as chief commercial officer, placing Devlin in charge of the company’s sales, marketing, business development, clinical research and customer care operations.

“Peter brings a distinguished track record in the diabetes and medical device industries, and we are extremely pleased to have him join Insulet’s management team,” Insulet president and CEO Duane DeSisto said in a statement.

Devlin previously worked as divisional VP global strategic marketing for diabetes care at Abbott Labs for 11 years.